Portal de Periódicos da CAPES

Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival

2010; Springer Nature; Volume: 46; Issue: 7 Linguagem: Inglês

10.1038/bmt.2010.218

1476-5365

Pablo Ramírez, Claudio G. Brunstein, Brian Miller, Todd E. DeFor, Daniel J. Weisdorf,

Renal Transplantation Outcomes and Treatments

Delayed platelet recovery (DPR) is common after allo-SCT. Insufficient data on risk factors and association with OS and TRM are available. We conducted a retrospective analysis of all allografts at the University of Minnesota between 2000 and 2005 to characterize the frequency of DPR (platelets <50 000/μL by day 60), risk factors and related complications. A total of 850 patients with hematological malignancies and benign disorders were included. Myeloablative (MA) conditioning was used in 65% of the patients and 45% received umbilical cord blood (UCB) grafts. The 60-day cumulative incidence of platelet recovery was 40% in UCB, 57% in unrelated donor (URD) and 74% in sibling donor. Multivariate analysis confirmed that the variables associated with DPR were MA (versus reduced intensity) conditioning, graft source other than sibling donor, ABO major mismatch, recipient CMV-positive serostatus, the presence of grade II–IV acute GVHD and slower neutrophil recovery. These data demonstrate that DPR is frequent after allogeneic hematopoietic cell transplantation, especially after UCB. DPR is a significant independent risk factor for increased TRM and poorer OS along with HLA-mismatched URD, but not UCB, grade II–IV acute GVHD, old age and advanced disease stage.